PEPID Pulse
  • Blog
  • Alerts
  • Press
  • pepid.com
Select Page

Another Study Shows Sugary Drink Consumption is Significantly Associated with Risk of Overall Cancer, and Breast Cancer

by PEPID Newsroom | Jul 10, 2019 | Alerts

According to the NutriNet-Sante prospective cohort study of 101,257 participants with the mean age of 42 and a medium follow-up of 5 years, sugary drinks like soda and fruit juices show a significant association of risk of overall cancer, and breast cancer....
First P13K inhibitor for Breast Cancer Gets FDA Approved

First P13K inhibitor for Breast Cancer Gets FDA Approved

by PEPID Newsroom | May 24, 2019 | Alerts

Pigray (alpelisib) tablets have been FDA approved to treat breast cancer in combination with FDA-approved endocrine therapy fulvestrant. Pigray is approved for postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2...

New Breast Cancer Screening Guidelines Recommend Discussing a Mammography Earlier

by PEPID Newsroom | Apr 16, 2019 | Alerts

The American College of Physicians (ACP) issued new guidance statements on breast cancer screening for asymptomatic women of average-risk. This issue follows a thorough review and inclusion of the following existing guidelines and associated evidence:    American...

Recent Posts

  • The Summer Injury Spike: Common ER Visits and How to Prevent Them
  • Men’s Health Month – Closing Gaps in Prevention and Early Detection
  • Beyond the Beach – Occupational Skin Cancer Risks in Outdoor Workers
  • Tackling Antimicrobial Resistance: How to fight back against the rise in tough cases
  • The ‘Forever Chemicals’ Crisis: What Healthcare Providers Need to Know About PFAS

Categories

  • Alerts
  • Emergency Medicine
  • Featured Posts
  • Nursing
  • Pharmacy
  • Press & Media
  • Primary Care
  • Uncategorized
PEPID, LLC. All rights reserved